Literature DB >> 3971375

A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice.

K Sekine, T Toida, M Saito, M Kuboyama, T Kawashima, Y Hashimoto.   

Abstract

Three kinds of morphologically distinct cell wall preparations were isolated from heat-killed Bifidobacterium infantis and examined for the relative antitumor efficacy with syngeneic Meth A fibrosarcoma in BALB/c mice. Ultrastructural examinations revealed that cell wall skeleton (CWS) did not retain morphologically recognizable cell wall structure but showed fibrous structure. By contrast, a new cell wall preparation, whole peptidoglycan (WPG), which was isolated from whole cells without being subjected to physically destructive methods, completely retained the intact cell wall structure. When WPG was disrupted by sonic treatment, it retained some degree of physical integrity of cell wall structure, as compared with CWS. The results of chemical analysis indicated that the three cell wall preparations had similar chemical properties. A single s.c. injection of either CWS, WPG, or sonicated WPG in a mixture with tumor cells resulted in a significant suppression of the tumor growth. They were of equally high activity. However, when WPG, sonicated WPG, or CWS was injected intralesionally five times into mice bearing 5-day-old tumors, the incidence of complete tumor regression was demonstrated to decrease in the order of 70, 40, and 20%, respectively. The in vitro cytotoxicity test excluded the possibility that the tumor cell destruction was the result of direct cytotoxicity of the cell wall preparations. From these findings, it was concluded that WPG was an active stimulator of host-mediated response at the tumor-growing sites.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3971375

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

Review 1.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

2.  The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition.

Authors:  Elise L Ma; Yoon Jeong Choi; Jinyoung Choi; Charalabos Pothoulakis; Sang Hoon Rhee; Eunok Im
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

3.  Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2.

Authors:  Tetsuya Matsuguchi; Akimitsu Takagi; Takeshi Matsuzaki; Masato Nagaoka; Kimika Ishikawa; Teruo Yokokura; Yasunobu Yoshikai
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

4.  Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells.

Authors:  S Matsumoto; T Hara; T Hori; K Mitsuyama; M Nagaoka; N Tomiyasu; A Suzuki; M Sata
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

Review 5.  Genomic insights into bifidobacteria.

Authors:  Ju-Hoon Lee; Daniel J O'Sullivan
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

6.  Isolation and structural analysis of polysaccharide containing galactofuranose from the cell walls of Bifidobacterium infantis.

Authors:  Y Tone-Shimokawa; T Toida; T Kawashima
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

Review 7.  Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer.

Authors:  Constantine-Iosif Fotiadis; Christos-Nikolaou Stoidis; Basileios-Georgiou Spyropoulos; Eleftherios-Dimitriou Zografos
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

8.  Peptidoglycan from lactobacilli inhibits interleukin-12 production by macrophages induced by Lactobacillus casei through Toll-like receptor 2-dependent and independent mechanisms.

Authors:  Kan Shida; Junko Kiyoshima-Shibata; Rumi Kaji; Masato Nagaoka; Masanobu Nanno
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

Review 9.  Intestinal microbiota, probiotics and human gastrointestinal cancers.

Authors:  Antonella Orlando; Francesco Russo
Journal:  J Gastrointest Cancer       Date:  2013-06

Review 10.  Antitumor mechanisms of bifidobacteria.

Authors:  Hongyun Wei; Linlin Chen; Guanghui Lian; Junwen Yang; Fujun Li; Yiyou Zou; Fanggen Lu; Yani Yin
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.